Protective Role of Carvacrol Against Diclofenac-Induced Cardiotoxicity: Effects on Oxidative Stress, Apoptosis, Inflammation, ER Stress and Autophagy

Basit Öğe Kaydı
dc.contributor.authorGül, Murat
dc.contributor.authorKandemir, Özge
dc.contributor.authorAkaras, Nurhan
dc.contributor.authorŞimsek, Hasan
dc.contributor.authorÇağlayan, Cüneyt
dc.date.accessioned2025-07-24T11:43:23Z
dc.date.available2025-07-24T11:43:23Z
dc.date.issued2025
dc.departmentTıp Fakültesi
dc.description.abstractDiclofenac (Diclo) is a widely used nonsteroidal anti-inflammatory drug (NSAID) for managing pain, inflammation, and joint disorders. However, studies have shown that diclofenac may induce cardiotoxicity via oxidative stress, inflammation, apoptosis, ER stress, and autophagy. Carvacrol (CRV), a natural monoterpenoid phenol, exhibits antioxidant, anti-inflammatory, and cytoprotective properties. This study aimed to evaluate the protective effects of carvacrol against diclofenac-induced cardiotoxicity by assessing relevant molecular and histological markers.MethodsIn the study, 35 Wistar rats were divided into 5 groups; Control, CRV, Diclo, Diclo + CRV25, and Diclo + CRV50. Diclo was administered intraperitoneally at a dose of 50 mg/kg. CRV (25 mg/kg and 50 mg/kg) was administered via oral gavage. Biochemical, molecular, and histological methods were used to investigate indicators of oxidative stress, inflammation, apoptosis, and ER stress damage in heart tissue.ResultsCRV treatment attenuated oxidative stress damage by reversing Diclo-induced changes: it significantly increased the levels of antioxidant markers (SOD, CAT, GPx, GSH) and decreased MDA levels, a marker of lipid peroxidation. CRV also reduced inflammatory mediators such as NF-kappa B and other pro-inflammatory cytokines. Furthermore, CRV downregulated apoptotic markers Bax and Caspase-3 while upregulating anti-apoptotic markers AKT-2 and Bcl-2. ER stress-associated proteins (ATF-6, PERK, IRE1, GRP-78) elevated by Diclo were also reduced by CRV. In addition, CRV alleviated structural and functional cardiac damage induced by Diclo.ConclusionOverall, CRV may be an effective treatment option for cardiac tissue damage caused by Diclo toxicity and may reduce the level of damage.
dc.identifier.doi10.1007/s44411-025-00268-5
dc.identifier.issn0006-9248 / 1336-0345
dc.identifier.urihttps://dx.doi.org/10.1007/s44411-025-00268-5
dc.identifier.urihttps://hdl.handle.net/20.500.12451/13573
dc.identifier.wosWOS:001529116700001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.institutionauthorGül, Murat
dc.institutionauthorKandemir, Özge
dc.institutionauthorAkaras, Nurhan
dc.institutionauthorŞimsek, Hasan
dc.language.isoen
dc.publisherSpringer Nature
dc.relation.ispartofBratislava Medical Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectApoptosis
dc.subjectCardiotoxicity
dc.subjectCarvacrol
dc.subjectDiclofenac
dc.subjectOxidative Stress
dc.titleProtective Role of Carvacrol Against Diclofenac-Induced Cardiotoxicity: Effects on Oxidative Stress, Apoptosis, Inflammation, ER Stress and Autophagy
dc.typeArticle

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Makale Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu